Cancer Research Cancer Health Disparities Conference 2009
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 51, 813-819, February 1, 1991]
© 1991 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Huang, M.-T.
Right arrow Articles by Conney, A. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Huang, M.-T.
Right arrow Articles by Conney, A. H.

Inhibitory Effects of Curcumin on in Vitro Lipoxygenase and Cyclooxygenase Activities in Mouse Epidermis1

Mou-Tuan Huang, Thomas Lysz, Thomas Ferraro, Tanveer F. Abidi, Jeffrey D. Laskin and Allan H. Conney2

Laboratory for Cancer Research, Department of Chemical Biology and Pharmacognosy, College of Pharmacy, Rutgers, The State University of New Jersey, Piscataway, New Jersey 08855-0789 [M-T. H., T. F., A. H. C.], Department of Surgery, UMDNJ-New Jersey Medical School, Newark, New Jersey 07103-2757 [T. L.], and Department of Environmental and Community Medicine, UMDNJ-Robert Wood Johnson Medical School, Piscataway, New Jersey 08854 [T. F. A., J. D. L.]

Topical application of curcumin, the yellow pigment in turmeric and curry, strongly inhibited 12-O-tetradecanoylphorbol-13-acetate (TPA)-induced ornithine decarboxylase activity, DNA synthesis, and tumor promotion in mouse skin (Huang et al., Cancer Res., 48: 5941–5946, 1988). Chlorogenic acid, caffeic acid, and ferulic acid (structurally related dietary compounds) were considerably less active. In the present study, topical application of curcumin markedly inhibited TPA- and arachidonic acid-induced epidermal inflammation (ear edema) in mice, but chlorogenic acid, caffeic acid, and ferulic acid were only weakly active or inactive. The in vitro addition of 3, 10, 30, or 100 µM curcumin to cytosol from homogenates of mouse epidermis inhibited the metabolism of arachidonic acid to 5-hydroxyeicosatetraenoic acid (5-HETE) by 40, 60, 66, or 83%, respectively, and the metabolism of arachidonic acid to 8-HETE was inhibited by 40, 51, 77, or 85%, respectively [IC50 (concentration needed for 50% inhibition) = 5–10 µM]. Chlorogenic acid, caffeic acid, or ferulic acid (100 µM) inhibited the metabolism of arachidonic acid to 5-HETE by 36, 10, or 16%, respectively, and these hydroxylated cinnamic acid derivatives inhibited the metabolism of arachidonic acid to 8-HETE by 37, 20, or 10%, respectively (IC50 > 100 µM). The metabolism of arachidonic acid to prostaglandin E2, prostaglandin F2{alpha}, and prostaglandin D2 by epidermal microsomes was inhibited approximately 50% by the in vitro addition of 5–10 µM curcumin. Chlorogenic acid, caffeic acid, and ferulic acid (100 µM) were inactive. In vitro rat brain protein kinase C activity was not affected by 50–200 µM curcumin, chlorogenic acid, caffeic acid, or ferulic acid. The inhibitory effects of curcumin, chlorogenic acid, caffeic acid, and ferulic acid on TPA-induced tumor promotion in mouse epidermis parallel their inhibitory effects on TPA-induced epidermal inflammation and epidermal lipoxygenase and cyclooxygenase activities.

1 This work was supported in part by Outstanding Investigator Grant CA 49756 from the National Cancer Institute.

2 To whom requests for reprints should be addressed.

Received 8/ 9/90. Accepted 11/12/90.




This article has been cited by other articles:


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
S. K. Vareed, M. Kakarala, M. T. Ruffin, J. A. Crowell, D. P. Normolle, Z. Djuric, and D. E. Brenner
Pharmacokinetics of Curcumin Conjugate Metabolites in Healthy Human Subjects
Cancer Epidemiol. Biomarkers Prev., June 1, 2008; 17(6): 1411 - 1417.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. J. Kim, T. G. Son, H. R. Park, M. Park, M.-S. Kim, H. S. Kim, H. Y. Chung, M. P. Mattson, and J. Lee
Curcumin Stimulates Proliferation of Embryonic Neural Progenitor Cells and Neurogenesis in the Adult Hippocampus
J. Biol. Chem., May 23, 2008; 283(21): 14497 - 14505.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
D. Deeb, H. Jiang, X. Gao, S. Al-Holou, A. L. Danyluk, S. A. Dulchavsky, and S. C. Gautam
Curcumin [1,7-Bis(4-hydroxy-3-methoxyphenyl)-1-6-heptadine-3,5-dione; C21H20O6] Sensitizes Human Prostate Cancer Cells to Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand/Apo2L-Induced Apoptosis by Suppressing Nuclear Factor-{kappa}B via Inhibition of the Prosurvival Akt Signaling Pathway
J. Pharmacol. Exp. Ther., May 1, 2007; 321(2): 616 - 625.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
M. M. LoTempio, M. S. Veena, H. L. Steele, B. Ramamurthy, T. S. Ramalingam, A. N. Cohen, R. Chakrabarti, E. S. Srivatsan, and M. B. Wang
Curcumin Suppresses Growth of Head and Neck Squamous Cell Carcinoma
Clin. Cancer Res., October 1, 2005; 11(19): 6994 - 7002.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
N. Jurrmann, R. Brigelius-Flohe, and G.-F. Bol
Curcumin Blocks Interleukin-1 (IL-1) Signaling by Inhibiting the Recruitment of the IL-1 Receptor-Associated Kinase IRAK in Murine Thymoma EL-4 Cells
J. Nutr., August 1, 2005; 135(8): 1859 - 1864.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
G. Garcea, D. P. Berry, D. J.L. Jones, R. Singh, A. R. Dennison, P. B. Farmer, R. A. Sharma, W. P. Steward, and A. J. Gescher
Consumption of the Putative Chemopreventive Agent Curcumin by Cancer Patients: Assessment of Curcumin Levels in the Colorectum and their Pharmacodynamic Consequences
Cancer Epidemiol. Biomarkers Prev., January 1, 2005; 14(1): 120 - 125.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
J. Hong, M. Bose, J. Ju, J.-H. Ryu, X. Chen, S. Sang, M.-J. Lee, and C. S. Yang
Modulation of arachidonic acid metabolism by curcumin and related {beta}-diketone derivatives: effects on cytosolic phospholipase A2, cyclooxygenases and 5-lipoxygenase
Carcinogenesis, September 1, 2004; 25(9): 1671 - 1679.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
D. Deeb, H. Jiang, X. Gao, M. S. Hafner, H. Wong, G. Divine, R. A. Chapman, S. A. Dulchavsky, and S. C. Gautam
Curcumin sensitizes prostate cancer cells to tumor necrosis factor-related apoptosis-inducing ligand/Apo2L by inhibiting nuclear factor-{kappa}B through suppression of I{kappa}B{alpha} phosphorylation
Mol. Cancer Ther., July 1, 2004; 3(7): 803 - 812.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Balasubramanian and R. L. Eckert
Green Tea Polyphenol and Curcumin Inversely Regulate Human Involucrin Promoter Activity via Opposing Effects on CCAAT/Enhancer-binding Protein Function
J. Biol. Chem., June 4, 2004; 279(23): 24007 - 24014.
[Abstract] [Full Text] [PDF]


Home page
Toxicol PatholHome page
Curcumin Derivatives: Potential for Prostate Cancer Management: ADDANKI P. KUMAR, GRETCHEN E. GARCIA, RITA GHOSH, RAJENDRAN V. RAJNARAYANAN,1 WILLIAM L. ALWORTH,1 AND THOMAS J. SLAGA, Center for Cancer Causation and Prevention, AMC Cancer Research Center and University of Colorado Comprehensive Cancer Center, Denver, Colorado 80214; 1 Department of Chemistry, Tulane University, New Orleans, Louisiana 70118
Toxicol Pathol, January 1, 2004; 32(1): 161 - 163.
[PDF]


Home page
J. Immunol.Home page
H. Y. Kim, E. J. Park, E.-h. Joe, and I. Jou
Curcumin Suppresses Janus Kinase-STAT Inflammatory Signaling through Activation of Src Homology 2 Domain-Containing Tyrosine Phosphatase 2 in Brain Microglia
J. Immunol., December 1, 2003; 171(11): 6072 - 6079.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
A. H. Conney
Enzyme Induction and Dietary Chemicals as Approaches to Cancer Chemoprevention: The Seventh DeWitt S. Goodman Lecture
Cancer Res., November 1, 2003; 63(21): 7005 - 7031.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
X. Bai, F. Cerimele, M. Ushio-Fukai, M. Waqas, P. M. Campbell, B. Govindarajan, C. J. Der, T. Battle, D. A. Frank, K. Ye, et al.
Honokiol, a Small Molecular Weight Natural Product, Inhibits Angiogenesis in Vitro and Tumor Growth in Vivo
J. Biol. Chem., September 12, 2003; 278(37): 35501 - 35507.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
J.-H. Woo, Y.-H. Kim, Y.-J. Choi, D.-G. Kim, K.-S. Lee, J. H. Bae, D. S. Min, J.-S. Chang, Y.-J. Jeong, Y. H. Lee, et al.
Molecular mechanisms of curcumin-induced cytotoxicity: induction of apoptosis through generation of reactive oxygen species, down-regulation of Bcl-XL and IAP, the release of cytochrome c and inhibition of Akt
Carcinogenesis, July 1, 2003; 24(7): 1199 - 1208.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
B. Salh, K. Assi, V. Templeman, K. Parhar, D. Owen, A. Gomez-Munoz, and K. Jacobson
Curcumin attenuates DNB-induced murine colitis
Am J Physiol Gastrointest Liver Physiol, June 9, 2003; 285(1): G235 - G243.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S. Somasundaram, N. A. Edmund, D. T. Moore, G. W. Small, Y. Y. Shi, and R. Z. Orlowski
Dietary Curcumin Inhibits Chemotherapy-induced Apoptosis in Models of Human Breast Cancer
Cancer Res., July 1, 2002; 62(13): 3868 - 3875.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
S. Perkins, R. D. Verschoyle, K. Hill, I. Parveen, M. D. Threadgill, R. A. Sharma, M. L. Williams, W. P. Steward, and A. J. Gescher
Chemopreventive Efficacy and Pharmacokinetics of Curcumin in the Min/+ Mouse, a Model of Familial Adenomatous Polyposis
Cancer Epidemiol. Biomarkers Prev., June 1, 2002; 11(6): 535 - 540.
[Abstract] [Full Text] [PDF]


Home page
Integr Cancer TherHome page
J. M. Wallace
Nutritional and Botanical Modulation of the Inflammatory Cascade--Eicosanoids, Cyclooxygenases, and Lipoxygenases-- As an Adjunct in Cancer Therapy
Integr Cancer Ther, March 1, 2002; 1(1): 7 - 37.
[Abstract] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
C. R. Ireson, D. J. L. Jones, S. Orr, M. W. H. Coughtrie, D. J. Boocock, M. L. Williams, P. B. Farmer, W. P. Steward, and A. J. Gescher
Metabolism of the Cancer Chemopreventive Agent Curcumin in Human and Rat Intestine
Cancer Epidemiol. Biomarkers Prev., January 1, 2002; 11(1): 105 - 111.
[Abstract] [Full Text]


Home page
CarcinogenesisHome page
R. J. Anto, A. Mukhopadhyay, K. Denning, and B. B. Aggarwal
Curcumin (diferuloylmethane) induces apoptosis through activation of caspase-8, BID cleavage and cytochrome c release: its suppression by ectopic expression of Bcl-2 and Bcl-xl
Carcinogenesis, January 1, 2002; 23(1): 143 - 150.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
I. Shureiqi and S. M. Lippman
Lipoxygenase Modulation to Reverse Carcinogenesis
Cancer Res., September 1, 2001; 61(17): 6307 - 6312.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
C. Ireson, S. Orr, D. J. L. Jones, R. Verschoyle, C.-K. Lim, J.-L. Luo, L. Howells, S. Plummer, R. Jukes, M. Williams, et al.
Characterization of Metabolites of the Chemopreventive Agent Curcumin in Human and Rat Hepatocytes and in the Rat in Vivo, and Evaluation of Their Ability to Inhibit Phorbol Ester-induced Prostaglandin E2 Production
Cancer Res., February 1, 2001; 61(3): 1058 - 1064.
[Abstract] [Full Text]


Home page
CarcinogenesisHome page
H. Inano, M. Onoda, N. Inafuku, M. Kubota, Y. Kamada, T. Osawa, H. Kobayashi, and K. Wakabayashi
Potent preventive action of curcumin on radiation-induced initiation of mammary tumorigenesis in rats
Carcinogenesis, October 1, 2000; 21(10): 1835 - 1841.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
N. N. Mahmoud, A. M. Carothers, D. Grunberger, R. T. Bilinski, M. R. Churchill, C. Martucci, H. L. Newmark, and M. M. Bertagnolli
Plant phenolics decrease intestinal tumors in an animal model of familial adenomatous polyposis
Carcinogenesis, May 1, 2000; 21(5): 921 - 927.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
H. Inano, M. Onoda, N. Inafuku, M. Kubota, Y. Kamada, T. Osawa, H. Kobayashi, and K. Wakabayashi
Chemoprevention by curcumin during the promotion stage of tumorigenesis of mammary gland in rats irradiated with {gamma}-rays
Carcinogenesis, June 1, 1999; 20(6): 1011 - 1018.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
F. Zhang, N. K. Altorki, J. R. Mestre, K. Subbaramaiah, and A. J. Dannenberg
Curcumin inhibits cyclooxygenase-2 transcription in bile acid- and phorbol ester-treated human gastrointestinal epithelial cells
Carcinogenesis, March 1, 1999; 20(3): 445 - 451.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1991 by the American Association for Cancer Research.